EEG Patterns Predicting Clobazam Response in Refractory Status Epilepticus in Adults

Manmatharayan, Arichena; Andrade-Machado, Rene; Marawar, Rohit; Lee, Paul; Lagnf, Abdalhamid; Souidan, Hassan; Ataya, Taha; Abdelhak, Farah; Thomas, Rohan; Fakhouri, Rami; Motii, Younes; Rehman, Sarah; Durban, Margerie; Parker, Dennis; Mohamed, Wazim; Elsayed, Mona

doi:10.2478/joepi-2024-0002

References

Hammer H., Ebert B., Jensen H.S., Jensen A.A.: Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes. PLoS One, 2015 Mar 23; 10 (3): e0120239. doi: 10.1371/journal.pone.0120239. PMID: 25798598; PMCID: PMC4370687.
Open DOI Search in Google Scholar Back to article
Huddart R., Leeder J.S., Altman R.B., Klein T.E.: PharmGKB summary: clobazam pathway, pharmacokinetics. Pharmacogenet Genomics, 2018, 28: 110–115. doi: 10.1097/FPC.0000000000000327. PMID: 29517622; PMCID: PMC5914180.
Open DOI Search in Google Scholar Back to article
Madžar D., Geyer A., Knappe R.U., Gollwitzer S., Kuramatsu J.B., Gerner S.T. et al.: Effects of clobazam for treatment of refractory status epilepticus. BMC Neurol., 2016, 16: 202. doi: 10.1186/s12883-016-0724-y. PMID: 27769254; PMCID: PMC5073816.
Open DOI Search in Google Scholar Back to article
Maille J.M., Hanna S.S., Shah D.N.: Addition of clobazam successfully treating drug resistant seizures in Heidenhain variant Creutzfeldt Jakob disease: A case report. Epilepsy Behav. Rep., 2023, 21: 100585. doi: 10.1016/j.ebr.2023.100585. PMID: 36698381; PMCID: PMC9867951.
Open DOI Search in Google Scholar Back to article
Marawar R., Basha M., Mahulikar A., Desai A., Suchdev K., Shah A.: Updates in Refractory Status Epilepticus. Crit Care Res Pract, 2018; 2018: 9768949. doi: 10.1155/2018/9768949. PMID: 29854452; PMCID: PMC5964484.
Open DOI Search in Google Scholar Back to article
Sankar R.: GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. CNS Drugs, 2012, 26: 229–44. doi: 10.2165/11599020-000000000-00000. PMID: 22145708.
Open DOI Search in Google Scholar Back to article
Sivakumar S., Ibrahim M., Parker D. Jr, Norris G., Shah A., Mohamed W.: Clobazam: An effective add-on therapy in refractory status epilepticus. Epilepsia, 2015, 56: e83–9. doi: 10.1111/epi.13013. Epub 2015 May 12. PMID: 25963810.
Open DOI Search in Google Scholar Back to article
Storustovu S.I., Ebert B.: Pharmacological characterization of agonists at delta-containing GABAA receptors: functional selectivity for extra synaptic receptors is dependent on the absence of gamma2. J. Pharmacol. Exp. Ther., 2006, 316: 1351–1359.
Search in Google Scholar Back to article
Thome-Souza S., Klehm J., Jackson M., Kadish N.E., Manganaro S., Fernández I.S. et al.: Clobazam higher-evening differential dosing as an add-on therapy in refractory epilepsy. Seizure, 2016, 1–6. doi 10.1016/j.seizure.2016.05.014. Epub 2016 May 27. PMID: 27281712.
Open DOI Search in Google Scholar Back to article
Vasquez A., Gaínza-Lein M., Sánchez Fernández I., Abend N.S., Anderson A., Brenton J.N. et al.: Pediatric Status Epilepticus Research Group (pSERG). Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. Pediatr. Neurol., 2018, 86: 33–41. doi: 10.1016/j.pediatrneurol.2018.06.004. Epub 2018 Jul 11. PMID: 30075875.
Open DOI Search in Google Scholar Back to article

EEG Patterns Predicting Clobazam Response in Refractory Status Epilepticus in Adults

References

Paradigm

My account